STOCK TITAN

Stevanato Group S.p.A. - $STVN STOCK NEWS

Welcome to our dedicated page for Stevanato Group S.p.A. news (Ticker: $STVN), a resource for investors and traders seeking the latest updates and insights on Stevanato Group S.p.A. stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Stevanato Group S.p.A.'s stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Stevanato Group S.p.A.'s position in the market.

Rhea-AI Summary
Stevanato Group S.p.A. (NYSE: STVN) has introduced two new offerings for efficient small batch pharmaceutical manufacturing: the EZ-fill® Kit and the non-GMP laboratory fill and finish service at its Technology Excellence Centers. The EZ-fill® Kit provides fast access to a customizable and versatile solution for efficiently filling small batches with high-quality injectable formulations. The surge in biopharmaceuticals treating various diseases signals significant growth potential for pharmaceutical companies. The kit brings enhanced levels of quality and safety to patients and is expected to be available commercially beginning in the second quarter of 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
none
-
Rhea-AI Summary
Stevanato Group S.p.A. (NYSE: STVN) will participate in the 42nd Annual J.P. Morgan Healthcare Conference from January 8-11, 2024, in San Francisco. The company will present on January 10th at 8:15 a.m.(PT) and provide a live webcast on their website. A replay of the webcast will be available for approximately 90 days after the event.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.99%
Tags
conferences
-
Rhea-AI Summary
Stevanato Group (NYSE: STVN) Wins 2023 Pharma Innovation Award for Mavis™ Combi Visual Inspection Machine, Recognized for Excellence and Leadership in Implementing Equipment and Technology to Respond to Pharma Companies’ Needs. The Mavis™ Combi is a cutting-edge solution designed to enhance visual inspection of primary packaging and drugs, providing advanced performance, flexibility, and speed. It can handle a diverse array of glass primary containers, accurately identifying particles, cosmetic defects, and closure integrity issues, ensuring the highest standards of product quality and safety.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.12%
Tags
none
Rhea-AI Summary
Stevanato Group S.p.A. (NYSE: STVN) announces participation in Jefferies London Healthcare Conference, presenting on November 15, 2023 at 10:00 a.m. GMT. The live webcast and replay will be available on the Company’s website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.58%
Tags
conferences
-
Rhea-AI Summary
Stevanato Group, a leading provider of drug containment and delivery solutions, announced its Q3 2023 financial results. Revenue increased 11% to €271.4 million, with high-value solutions accounting for 32% of total revenue. Net profit increased 4% to €37.9 million, and adjusted net profit increased 6% to €40.1 million. The company reiterates its full year 2023 guidance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.19%
Tags
-
Rhea-AI Summary
Stevanato Group to release Q3 2023 financial results and host conference call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
conferences earnings
Rhea-AI Summary
Stevanato Group passes resolution at Extraordinary General Meeting of Shareholders
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.39%
Tags
none
-
Rhea-AI Summary
Stevanato Group S.p.A. to livestream Capital Markets Day on September 27, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.56%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.33%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
conferences earnings
Stevanato Group S.p.A.

NYSE:STVN

STVN Rankings

STVN Stock Data

5.76B
41.66M
2.13%
77.59%
0.87%
Glass Container Manufacturing
Manufacturing
Link
United States of America
Piombino Dese

About STVN

founded in 1949, stevanato group is committed to create systems, processes and services that guarantee the integrity of parenteral medicines. it is comprised of two operational divisions: - pharmaceutical systems (ompi and balda brands): specialized in ready-to-use glass containers and bulk primary packaging (syringes, cartridges, vials and ampoules); high quality and high precision plastic solutions for diagnostic, pharmaceutical and medical device applications. - engineering systems (spami, optrel, innoscan and svm brands): specialized in glass forming technology, inspection systems, assembly, packaging machines and serialization solutions for the pharmaceutical industry. these two divisions enjoy a close, synchronous relationship, featuring daily exchanges which ensure that stevanato group has complete control over the entire production process, from purchasing the finest raw materials to offering exceptional after-sales customer service. the group also benefits from the sglab activ